To compare the effectiveness of intravenous magnesium sulphate and paracetamol in reducing the pain after surgery in patients undergoing Total abdominal hysterectomy

Phase 4

• Conditions: Health Condition 1: N939- Abnormal uterine and vaginal bleeding, unspecifiedHealth Condition 2: N926- Irregular menstruation, unspecified

• Registration Number: CTRI/2023/07/055582
• Lead Sponsor: ANU ELSA BOBBY

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 21 August 2023

Recruitment & Eligibility

• Status: ot Yet Recruiting
• Sex: Not specified
• Target Recruitment: 0

Inclusion Criteria

1.ASA grade 1 and 2 patients

Exclusion Criteria

1.Emergency surgeries

2.BMI > 40kg/m2

3.Patients with known allergy to the drugs used in study

4.Patients with renal insufficiency

5.Neuromuscular diseases

6.Hepatic dysfunction

7.Cardiac disease

8.Previous oncological surgery

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Pain score in both the groupTimepoint: 0hr, 4hr, 8 hr, 12hr , 16hr, 20 hr , 24hr

Secondary Outcome Measures

Name	Time	Method
â?¢Total analgesic requirement in the two groups in first 24 hours <br/ ><br>â?¢Time (in minutes) to request first analgesic in both groups <br/ ><br>â?¢Frequency of occurrence of side-effects of magnesium sulphateTimepoint: 0 hour, 4 hours, 8 hours , 12 hours , 16 hours, 20 hours, 24 hours